Atossa Therapeutics Inc (NASDAQ:ATOS)

2.40
Delayed Data
As of Sep 21
 -0.02 / -0.82%
Today’s Change
0.76
Today|||52-Week Range
5.08
+52.87%
Year-to-Date
Atossa's COVID-19 nasal spray receives second positive safety review
Sep 17 / Seeking Alpha - Paid Partner Content
Atossa files for $100M mixed shelf
Sep 02 / Seeking Alpha - Paid Partner Content
SRNE, IMGN among premarket gainers
Sep 17 / Seeking Alpha - Paid Partner Content
WDAY, ULTA among premarket gainers.
Aug 28 / Seeking Alpha - Paid Partner Content